Completed PHASE2 INTERVENTIONAL 2-arm NCT01075763

A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease (REAL)

Pilot Trial of Interferon Beta-1a in Alzheimer's Disease

Sponsor: Merck KGaA, Darmstadt, Germany

Interventions Interferon beta-1a Placebo

Updated 7 times since 2017 Last updated: Jan 20, 2014 Started: Nov 30, 2004 Primary completion: May 31, 2008 Completion: May 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01075763, this PHASE2 trial focuses on Alzheimer's Disease and remains completed. Sponsored by Merck KGaA, Darmstadt, Germany, it has been updated 7 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2019 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — Jan 2019 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Nov 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Merck KGaA, Darmstadt, Germany
Merck Serono S.P.A., Italy

Data source: Merck KGaA, Darmstadt, Germany

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Catania, Italy